High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Hagar Z Pikkel-Geva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Adenoviridae Infections, Hematopoietic Stem Cell Transplantation, Adenovirus Infections, Human, Adenoviruses, Human. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
The gastrointestinal (GI) tract is a major human adenovirus (HAdV) replication site in patients undergoing hematopoietic stem cell transplantation (HSCT), yet the prevalence and correlates of HAdV GI infection in this setting have remained poorly recognized, especially among adult HSCT recipients. Design or methods We retrospectively studied the prevalence and risk factors of HAdV GI‐tissue infection in HSCT recipients (73 adults and 15 children) with GI symptoms who underwent GI‐tissue biopsy between January‐2012 and December‐2017. The presence of HAdV in the GI tissues was determined by real‐time PCR.
Results
HAdV GI‐tissue infection was detected in 21 (23.9%) patients, with similar infection rates identified in adults and children. GI‐tissue detection was more common at late (>100 days) compared to early times post‐transplantation (50% vs. 12.9%, p < .001). The presence of bloody diarrhea, Arab ethnicity ( p = .014) and concurrent cytomegalovirus GI‐tissue detection ( p = .025) were significantly correlated with HAdV GI‐tissue infection, while chronic graft versus host disease was of borderline association ( p = .055).
Conclusions
Our findings reveal a high rate and new clinical‐demographic correlates of HAdV GI‐tissue infection in adult and pediatric HSCT recipients with GI symptoms. The findings highlight the need for future prospective studies to assess the relatedness of HAdV infection to the GI symptoms, and the prevalence, impact, and treatment of HAdV GI infection in HSCT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
- Bone Marrow Transplantation and Cancer Immunotherapy Department, Hadassah University Medical Center, Jerusalem, Israel.
- Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.
- Pediatric Infectious Diseases Unit, Faculty of Medicine, Hadassah Medical Center, Jerusalem, Israel.
ORCID-Profile: Ehud Even-Or, Batia Avni
Zitieren
APA
Pikkel-Geva, H. Z., Grisariu, S., Rivkin, M., Stepensky, P., Strahilevitz, J., Averbuch, D., Orit, C., Even-Or, E., Zaidman, I., Zimran, E., Wolf, D. G., & Avni, B. (2023). High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15098
Vancouver
Pikkel-Geva HZ, Grisariu S, Rivkin M, Stepensky P, Strahilevitz J, Averbuch D, et al. High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15098
BibTeX
@article{PikkelGeva2023,
author = {Pikkel-Geva, Hagar Z and Grisariu, Sigal and Rivkin, Mila and Stepensky, Polina and Strahilevitz, Jacob and Averbuch, Dina and Orit, Caplan and Even-Or, Ehud and Zaidman, Irina and Zimran, Eran and Wolf, Dana G and Avni, Batia},
title = {High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15098}
}
EUVIMED